Hosted on MSN

Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week

Regencell Bioscience Holdings Ltd (3,500% Jump in Message Volume) Hong Kong-based Regencell focuses on traditional Chinese medicine for neurocognitive disorders, particularly ADHD and autism. Reports ...
Hosted on MSN

TC BioPharm reports progress in AML treatment trial

EDINBURGH, Scotland - TC BioPharm (Holdings) PLC (NASDAQ: TCBP), a biotechnology firm with a market capitalization of $33.08 million engaged in developing gamma-delta T cell therapies, announced today ...
Nasdaq

TC BioPharm's TCB008 Shows Promising Results In Cohort A Of Phase 2B AML Trial

(RTTNews) - TC BioPharm (TCBP), a clinical-stage biotechnology company, on Thursday announced the successful completion of dosing for Cohort A in the ACHIEVE Phase 2B UK clinical trial. The trial ...
GEN

How TC BioPharm Cut 200 Manufacturing Steps and Improved Products

TC BioPharm eliminated approximately 200 steps from its allogeneic CAR-T biomanufacturing process, reducing hands-on manufacturing time by half and cutting production costs to a fraction of the ...
Nasdaq

TC BioPharm Advances Strategic Financial Initiative with New ADS Offering

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks The latest announcement is out from ...
Seeking Alpha

TCBPY TC Biopharm (Holdings) Plc

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline ...
Yahoo Finance

Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA

SHENZHEN, China, Feb. 14, 2025 /PRNewswire/ -- Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05, Human Interferon α1b ...
pharmaphorum

Dance Biopharm to develop inhaled insulin with Phillips-Medisize

US biotech Dance Biopharm is to work with Phillips-Medisize, to develop a version of its inhaled insulin device that has data connectivity for better management of diabetes treatment. Inhaled insulin ...
FierceBiotech

Sino Biopharm buys Merck's PD-1xVEGF bispecific partner LaNova for up to $951M

The PD-1xVEGF dealmaking wave that has captivated Western pharma companies is now surging within China. Tuesday, Sino Biopharmaceutical said it will pay up to $951 million to acquire Chinese ...
Yahoo Finance

Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China

Sino Biopharm a leading Chinese pharmaceutical group, through CTTQ will oversee the development and commercialization of lanifibranor in Greater China Lanifibranor is an orally-available small ...
조선일보

CHA Vaccine and SML Biopharm collaborate on mRNA vaccine and therapy development

CHA Biotech's subsidiary CHA Vaccine announced on the 8th that it will jointly develop messenger ribonucleic acid (mRNA) vaccines and therapeutics with SML Biopharm. mRNA serves as a 'messenger' that ...